HCV-infected solid organ donors, direct-acting antivirals and the current challenges

Expert Review of Clinical Pharmacology ◽

10.1080/17512433.2020.1697677 ◽

2019 ◽

Vol 13 (1) ◽

pp. 7-14 ◽

Author(s):

Fabrizio Fabrizi ◽

Roberta Cerutti ◽

Marcelo Silva

Keyword(s):

Solid Organ ◽

Organ Donors ◽

Direct Acting Antivirals ◽

Download Full-text

Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation

Transplant Infectious Disease ◽

10.1111/tid.12972 ◽

2018 ◽

Vol 20 (6) ◽

pp. e12972 ◽

Author(s):

Marlina Mansour ◽

Lucas Hill ◽

Janice Kerr

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Organ Transplantation ◽

Solid Organ Transplantation ◽

Solid Organ ◽

Direct Acting Antivirals ◽

Download Full-text

High virological cure rate and low rate of reinfection in a project to eradicate HCV in people who inject drugs at risk for non-adherence to direct-acting antivirals in Vienna

10.1055/s-0038-1654606 ◽

2018 ◽

Author(s):

A Schütz ◽

C Schwanke ◽

E Gutic ◽

T Lang ◽

R Schubert ◽

...

Keyword(s):

At Risk ◽

People Who Inject Drugs ◽

Direct Acting Antivirals ◽

Cure Rate ◽

Direct Acting ◽

Download Full-text

Treatment outcomes for hepatitis C genotype 1 infection with direct acting antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)

10.26226/morressier.572768e5d462b8029237f545 ◽

2016 ◽

Author(s):

Stefan Mauss

Keyword(s):

Hepatitis C ◽

Treatment Outcomes ◽

Direct Acting Antivirals ◽

Download Full-text

Faculty Opinions recommendation of Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.716298015.791652971 ◽

2012 ◽

Author(s):

Varun Garg

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Direct Acting Antivirals ◽

Download Full-text

Faculty Opinions recommendation of Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969197.793470534 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Direct Acting Antivirals ◽

Virus Genotype ◽

Genotype 1B ◽

Download Full-text

Faculty Opinions recommendation of Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020309.793478810 ◽

2013 ◽

Author(s):

Arthur Kim

Keyword(s):

Direct Acting Antivirals ◽

Download Full-text

Faculty Opinions recommendation of Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718230957.793490174 ◽

2014 ◽

Author(s):

Christopher Cimarusti

Keyword(s):

Developing Countries ◽

Hepatitis C ◽

Large Scale ◽

Direct Acting Antivirals ◽

Treatment Access ◽

Direct Acting ◽

Minimum Costs ◽

Access Programs

Download Full-text

Faculty Opinions recommendation of Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726468907.793521728 ◽

2016 ◽

Author(s):

Doug Dieterich ◽

Dost Sarpel

Keyword(s):

Hepatocellular Carcinoma ◽

Direct Acting Antivirals ◽

Direct Acting ◽

Early Occurrence

Download Full-text

Faculty Opinions recommendation of Impact of All-Oral Direct-Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic Hepatitis C in the United States.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734161454.793557418 ◽

2019 ◽

Author(s):

Doug Dieterich ◽

Clara Rodriguez Rivas

Keyword(s):

United States ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

The United States ◽

Economic Outcomes ◽

Direct Acting Antivirals ◽

Download Full-text

All Oral Interferon-free Direct-acting Antivirals as Combination Therapies to Cure Hepatitis C

Current Molecular Medicine ◽

10.2174/1566524019666190104110439 ◽

2019 ◽

Vol 18 (7) ◽

pp. 409-435 ◽

Author(s):

Imran Shahid ◽

Munjed M. Ibrahim

Keyword(s):

Hepatitis C ◽

Combination Therapies ◽

Direct Acting Antivirals ◽

Download Full-text